Cidel Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.1M Buy
16,136
+13
+0.1% +$3.03K 0.2% 83
2026
Q1
$3.94M Buy
16,123
+1,540
+11% +$359K 0.22% 76
2025
Q4
$3.02M Sell
14,583
-935
-6% -$185K 0.21% 76
2025
Q3
$2.88M Sell
15,518
-178
-1% -$30.5K 0.17% 77
2025
Q2
$2.4M Sell
15,696
-374
-2% -$57.5K 0.14% 83
2025
Q1
$2.67M Sell
16,070
-268
-2% -$41.9K 0.17% 78
2024
Q4
$2.36M Buy
16,338
+440
+3% +$68.2K 0.16% 78
2024
Q3
$2.58M Sell
15,898
-531
-3% -$84.6K 0.18% 78
2024
Q2
$2.4M Buy
16,429
+650
+4% +$96.7K 0.19% 74
2024
Q1
$2.5M Sell
15,779
-1,170
-7% -$186K 0.19% 74
2023
Q4
$2.66M Buy
16,949
+10,710
+172% +$1.64M 0.11% 80
2023
Q3
$972K Sell
6,239
-162,463
-96% -$26.8M 0.05% 82
2023
Q2
$27.9M Buy
168,702
+12,325
+8% +$1.99M 1.26% 30
2023
Q1
$24.2M Buy
156,377
+454
+0.3% +$73.3K 1.11% 31
2022
Q4
$27.5M Buy
155,923
+1,153
+0.7% +$199K 1.29% 31
2022
Q3
$25.3M Sell
154,770
-26,418
-15% -$4.47M 1.2% 30
2022
Q2
$32.2M Buy
181,188
+3,626
+2% +$646K 1.37% 27
2022
Q1
$31.5M Sell
177,562
-3,410
-2% -$580K 1.15% 33
2021
Q4
$31M Sell
180,972
-16,800
-8% -$2.75M 1.15% 32
2021
Q3
$31.9M Sell
197,772
-163
-0.1% -$27.8K 1.3% 25
2021
Q2
$32.6M Buy
197,935
+14,453
+8% +$2.39M 1.32% 25
2021
Q1
$30.2M Buy
183,482
+72,088
+65% +$11.7M 1.36% 27
2020
Q4
$17.5M Sell
111,394
-63,835
-36% -$9.42M 0.99% 32
2020
Q3
$26.1M Sell
175,229
-892
-0.5% -$132K 1.48% 22
2020
Q2
$24.8M Sell
176,121
-32,873
-16% -$4.79M 1.12% 31
2020
Q1
$27.4M Sell
208,994
-4,726
-2% -$670K 1.39% 24
2019
Q4
$31.2M Buy
213,720
+3,604
+2% +$489K 1.29% 28
2019
Q3
$27.2M Buy
210,116
+1,222
+0.6% +$161K 1.32% 26
2019
Q2
$29.1M Buy
208,894
+2,986
+1% +$413K 1.48% 24
2019
Q1
$28.8M Buy
205,908
+7,477
+4% +$1M 1.57% 21
2018
Q4
$25.6M Buy
198,431
+25,261
+15% +$3.52M 1.64% 21
2018
Q3
$24M Sell
173,170
-18,941
-10% -$2.52M 1.06% 30
2018
Q2
$23.3M Buy
192,111
+12,553
+7% +$1.57M 1.04% 33
2018
Q1
$28.7M Sell
179,558
-4,611
-3% -$623K 1.31% 26
2017
Q4
$25.7M Sell
184,169
-262
-0.1% -$36.5K 1.11% 27
2017
Q3
$24M Buy
184,431
+5,292
+3% +$702K 1.08% 28
2017
Q2
$23.7M Buy
179,139
+3,175
+2% +$405K 1.1% 25
2017
Q1
$21.7M Buy
175,964
+5,173
+3% +$618K 1.05% 28
2016
Q4
$19.7M Buy
170,791
+12,956
+8% +$1.5M 0.98% 28
2016
Q3
$18.6M Buy
157,835
+8,362
+6% +$1.01M 1.03% 28
2016
Q2
$18.1M Buy
149,473
+5,467
+4% +$621K 1.05% 25
2016
Q1
$15.6M Buy
144,006
+1,965
+1% +$203K 0.93% 28
2015
Q4
$14.6M Buy
142,041
+2,281
+2% +$229K 0.93% 26
2015
Q3
$13M Buy
139,760
+8,100
+6% +$784K 0.82% 30
2015
Q2
$12.8M Buy
131,660
+7,694
+6% +$770K 0.56% 31
2015
Q1
$12.5M Buy
123,966
+16,976
+16% +$1.73M 0.64% 30
2014
Q4
$10.7M Buy
+106,990
New +$11.3M 0.51% 31

Other funds holding JNJ

Cidel Asset Management's JNJ Position: Q2 2026 in Review

Cidel Asset Management increased its Johnson & Johnson (JNJ) stake by 0.08% in Q2 2026, buying an estimated $3.03K and bringing the position to 16,136 shares worth $4.1M. The position accounts for 0.2% of the portfolio, ranked #83.

Cidel Asset Management first reported a position in JNJ in Q4 2014 and has held it in 47 quarters since. The position peaked at $32.6M in Q2 2021. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cidel Asset Management held 16,136 shares of Johnson & Johnson worth $4.1M as of Q2 2026.
  • Cidel Asset Management bought 13 Johnson & Johnson shares in Q2 2026, an estimated $3.03K.
  • Johnson & Johnson made up 0.2% of Cidel Asset Management's portfolio in Q2 2026, its #83 holding.
  • Cidel Asset Management first reported a position in Johnson & Johnson in Q4 2014 and has held it in 47 quarters since.
  • Cidel Asset Management's Johnson & Johnson position peaked at $32.6M in Q2 2021.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cidel Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.